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Background: Terson syndrome is defined as intraocular hemorrhage associated with  intracranial 
bleeding. This syndrome can occur in the event of intracranial hemorrhage or elevated intracra-
nial pressure. To our knowledge, it has never been associated with chronic myeloid leukemia. 
A 45-year-old woman suffering from chronic myeloid leukemia was referred to our clinic with 
Terson syndrome after intracranial bleeding. We followed this patient for a year, performing 
visual acuity assessment, fundus examination, color retinography, and A-scan and B-scan ultra-
sonography. At presentation, her best-corrected visual acuity on the right was 20/63 and on the 
left was 20/320. In the right eye, retinoscopy showed blurring of the optic margins surrounded 
by retinal and preretinal hemorrhages, preretinal fibrosis of the optic disc along the vascular 
arcades, and perivascular retinal infiltrates. In the left eye, the optic disc was surrounded by 
retinal and preretinal hemorrhages, and massive fibrosis with hard exudates and severe preretinal 
hemorrhage were observed at the posterior pole. Roth spots and many circular hemorrhages were 
noted at the periphery of the retina. A-scan and B-scan ultrasonography did not show intraocu-
lar leukemic infiltration. The clinical picture remained stable over the following 12 months. 
In this patient, we observed the ophthalmoscopic features of chronic myeloid leukemia, but 
also coexistence of features typical of Terson syndrome. To our knowledge, no similar cases 
have been reported previously.
Keywords: retinal disease, chronic myeloid leukemia, eye hemorrhage, intracranial 
hemorrhage
Introduction
Terson syndrome is defined as intraocular hemorrhage associated with intracranial 
bleeding. It was first described as an intraretinal hemorrhage following subarachnoid 
hemorrhage,1,2 but it was subsequently noted that it could occur in any case of intra-
cranial hemorrhage or elevated intracranial pressure, and includes accumulation of 
subretinal, retinal, preretinal (subhyaloidal), or vitreal blood. It is usually bilateral, 
and in most cases recovers spontaneously within a few months. Vitrectomy can be 
considered in the most severe cases.3
Case report
A 45-year-old woman suffering from intraocular hemorrhage associated with chronic 
myeloid leukemia complicated by subdural hematoma was referred to our institution. 
Chronic myeloid leukemia had been diagnosed 10 years earlier and the patient’s comor-
bidities were treated arterial hypertension, hepatitis B virus positivity, and orally treated 
type 2 diabetes mellitus diagnosed 3 years earlier. At presentation, she was in blast crisis 
for the second time and the disease was rapidly progressing. She was hospitalized in the 
Hematology-Oncology Department, University of Turin, with a very low platelet count 
(8,000/mm3) and red cell count (2,000 mm3), asthenia, fever, and occipital headache radi-
ating to the anterior parts. A severe subdural hematoma was discovered, with ventricular 
dilatation and signs of high intracranial pressure. She was treated with repeated platelet 
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transfusions and  conservative medical therapy. The patient’s 
condition improved slowly, with progressive reabsorption of 
the hematoma and normalization of ventricular morphology 
on brain computed tomography scan.
We followed up this patient for a year by assessment of 
visual acuity, fundus examination, color retinography, and 
A-scan and B-scan ultrasonography. The patient complained 
of visual impairment in the left eye since the onset of her 
neurological symptoms, and was referred to our clinic. At 
presentation, her best corrected visual acuity on the right 
was 20/63 and on the left was 20/320. Retinal examination 
of the right eye revealed blurring of the optic margins sur-
rounded by retinal and preretinal hemorrhages, preretinal 
fibrosis starting from the optic disc and extending along 
the vascular arcades, and perivascular retinal infiltrates 
(Figure 1A). Massive fibrosis with hard exudates and severe 
preretinal hemorrhage were observed in the left eye at the 
posterior pole (Figure 1B). The optic disc was surrounded 
by retinal and preretinal hemorrhages. Roth spots and 
many circular and preretinal hemorrhages were noted at 
the retinal periphery (Figure 1C). The other ocular struc-
tures were within normal limits. Ocular tension was good 
(right, 20 mmHg; left, 17 mmHg).
A-scan and B-scan ultrasonography showed similar 
 clinical features in both eyes, ie, an anechogenic vitreous 
cavity, a small increase in the thickness of the chorioretinal 
complex, and some minute retinal lines with higher reflec-
tivity, likely representing hemorrhages. The patient was 
monitored for 12 months, with no changes in her clinical 
and functional characteristics.
Discussion
Hematological disorders such as leukemia are often compli-
cated by hemorrhage. Ocular tissues can be involved, caus-
ing hyphema in the anterior chamber, vitreous hemorrhage, 
or retinal hemorrhage. The retina is compromised in more 
than 50% of patients with leukemia, with vessel tortuosity and 
dilatation seen in the early stages. Bleeding can subsequently 
occur in all layers and can be round or flame-shaped, and is 
usually associated with a white area (Roth’s spots) consisting 
of leukemic cells, debris, platelets, or emboli.4
We found bilateral retinal hemorrhages in our patient 
which were particularly concentrated around the optic nerve 
head, and associated with intracranial bleeding (subdural 
hematoma). This presentation reflects the clinical features 
of Terson syndrome. We found a large quantity of intraocu-
lar blood in the retinal layers and in the preretinal space, 
accompanied by blurring of the optic nerve head margins, 
massive preretinal fibrosis along the vascular arcades, hard 
exudates, Roth spots, and perivascular retinal infiltrates. This 
clinical picture is not typical of leukemia and could also help 
us to hypothesize about the mechanisms of entry of blood 
in Terson syndrome. To date, several theories have been 
proposed to explain how blood spreads into the eye. The 
various theories could be correct or may complement each 
other. After an intracranial hemorrhage and the subse-
quent increase in intracranial pressure, blood was thought 
to pass towards the intervaginal space of the optic nerve 
(ie, Schwalbe spaces), occluding the central retinal vein 
and causing bleeding at the level of the optic disc.5 Other 
authors suggest that the increase in pressure is transmitted 
by the retinal vein system in the orbit, causing occlusion at 
the level of the retinochoroidal anastomosis and bleeding 
from the vascular arcades, away from the optic disc.6 Some 
authors have found that blood from retinal veins may spread 
and accumulate between the internal limiting membrane 
and Muller cells.7 Finally, based on recent findings, it has 
been proposed that blood may also enter subretinally near 
the macula.8 In our case, the clinical presentation seems to 
be consistent with the first hypothesis, given that blood and 
Figure 1 terson syndrome: color retinography. (A, B) posterior pole in the right and left eye. (C) Inferior retinal periphery in the left eye.
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consequent fibrosis were found to be concentrated around 
the optic disc.
Therapeutic management of Terson syndrome depends on 
the position of the intraocular hemorrhage. For a vitreous or 
subhyaloid hemorrhage, treatment could be conservative, ie, 
based on periodic observation awaiting spontaneous resorp-
tion, or more aggressive, ie, pars plana vitrectomy. In several 
cases, spontaneous improvement is observed within a few 
months from the acute event. Therefore, according to some 
authors, vitrectomy should be delayed and considered only 
in severe or bilateral cases that do not show signs of recov-
ery.9 Surgical complications are generally rare, but they are 
possible and tend to be severe, even a long time after surgery 
(eg, retinal detachment and retinal tears, epiretinal membrane 
formation, cataract, macular hole formation, proliferative 
vitreoretinopathy, cystoid edema). However, a recent report 
suggests that early vitrectomy facilitates rapid and optimal 
visual recovery, thereby reducing the incidence of complica-
tions of vitreous hemorrhage (proliferative vitreoretinopathy 
and glaucoma).10 In conclusion, there are no clear specifi-
cations regarding surgical treatment in patients suffering 
from Terson syndrome. The optimal timing of surgery and 
functional outcomes are also uncertain.10
A surgical approach is not possible in the presence of 
intraretinal hemorrhage. Our patient presented with both 
intraretinal and preretinal hemorrhage. Because of this, 
combined with her poor general condition and the high 
risk of bleeding due to her low platelet count, a surgical 
approach could not completely resolve the problem and 
clinical  management was oriented towards a conservative 
approach.
Conclusion
In this patient, we observed the ophthalmoscopic features 
of chronic myeloid leukemia and coexistence of features 
typical of Terson syndrome. To our knowledge, no similar 
cases have been previously reported.
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